Research Translations

Landmark studies, decoded for South Asian biology.

Translation 1

Type 5 Diabetes

The Old Myth

Diabetes is type 1 or type 2. Lean patients are low-risk.

The Science

2025 WHO/IDF consensus formally classified a distinct form of diabetes in lean, young, undernourished patients — predominantly from South Asia and Sub-Saharan Africa. Beta-cell failure occurs without insulin resistance. The mechanism is different, the demographics are different, the treatment implications are different.

The Zinda Takeaway

A lean BMI does not protect against diabetes if you have The Fragile Engine. HbA1c and fasting glucose screening should apply to lean SA patients as well.

WHO/IDF Type 5 Diabetes Working Group. Lancet Global Health, 2025.Read Full Translation →
Translation 2

PHENOEINDY-2

The Old Myth

Indians are high-risk because of obesity and poor lifestyle choices.

The Science

240 lean Indian diabetics (BMI <23) underwent DEXA scanning. Despite normal BMI, they showed: elevated visceral adipose tissue, reduced muscle mass, normal insulin sensitivity but beta-cell failure. The thin-fat phenotype — our bodies store fat viscerally even when lean.

The Zinda Takeaway

BMI is the wrong tool for South Asian risk assessment. Body composition (visceral fat, muscle mass) is what matters.

Mohan V, et al. Diabetologia. 2024.Read Full Translation →
Translation 3

The Jaipur Biopsy Study

The Old Myth

More fat = more risk. Lose weight, reduce risk.

The Science

322 South Asians biopsied across 3 fat depots. Adipocyte SIZE — not fat mass — predicted insulin resistance. After adjusting for cell size, the relationship between fat mass and insulin resistance disappeared. M1/M2 macrophage ratio was elevated, indicating inflammatory fat.

The Zinda Takeaway

The sick fat cell concept (2.5 in the Zinda Framework) is not theoretical — it's biopsied and proven. Small amounts of dysfunctional fat are more dangerous than larger amounts of healthy fat.

Misra A, et al. Diabetes Care. 2023.Read Full Translation →